The anti-HER2 [57Co]Co-DOTA-Z2395-C and anti HER3 [57Co]Co-ZHER3 affibodies showed promising tumor uptake, rapid blood clearance, and good imaging properties in the models tested. The gene discussed is ERBB2; the disease is neoplasm.